Quick Answer: Bayer has proposed a $7.25 billion settlement to resolve roughly 125,000 lawsuits claiming Roundup weedkiller caused non-Hodgkin’s lymphoma. The settlement is pending court approval and would pay between $10,000 and $165,000 depending on your age, exposure type, and disease severity. It hasn’t been finalized yet — but if you or someone you love used Roundup and later developed NHL, this is worth following.
After years of courtroom battles, a $2.1 billion Georgia jury verdict, and a litigation saga that’s consumed Bayer since its $63 billion acquisition of Monsanto in 2018, the company has proposed a sweeping $7.25 billion settlement to end approximately 125,000 Roundup cancer lawsuits — with payouts potentially extending 21 years into the future.
The proposed settlement was filed February 17, 2026 in St. Louis Circuit Court in Missouri. It still requires a judge’s approval. If approved, it would create a long-term claims fund covering both current plaintiffs with pending cases and people diagnosed with non-Hodgkin’s lymphoma (NHL) in the future — as long as their exposure to Roundup happened before mid-February 2026, and their diagnosis comes within 16 years of the court’s final approval.
That’s a big window. And the dollar figures involved are significant enough that anyone who has used Roundup — whether professionally or in their backyard — should at minimum know this settlement exists.
What Roundup Cases Are Actually About
The lawsuits claim that glyphosate, the active ingredient in Roundup, causes non-Hodgkin’s lymphoma — a type of blood cancer. Bayer and its subsidiary Monsanto have long maintained the product is safe, citing U.S. EPA findings that glyphosate is “not likely” to cause cancer in humans.
The Science Is Genuinely Disputed: In 2015, the International Agency for Research on Cancer (IARC), an arm of the World Health Organization, classified glyphosate as “probably carcinogenic to humans” (Group 2A) based on studies of agricultural workers and animal data. The EPA, the European Food Safety Authority, and several other regulatory bodies disagree and maintain glyphosate does not pose a carcinogenic risk. Juries, however, have not always sided with the regulators.
Since the IARC ruling, verdicts in individual trials have split 13 wins for Bayer and 11 for plaintiffs. That includes a staggering $2.1 billion Georgia jury award in 2025. The litigation costs — financial and reputational — have clearly pushed Bayer toward a global resolution.
About 77,000 claims were already resolved separately before this proposed settlement. This new agreement targets the remaining 125,000 pending lawsuits plus future claimants.
What the Settlement Would Pay
Compensation isn’t one flat amount. It depends on three factors: how you were exposed, how old you were at diagnosis, and how severe your illness was.
These are averages, not guarantees. Actual payouts can vary based on individual case facts. And there’s a catch: some plaintiff attorneys already say those numbers are too low. Matt Clement, an attorney representing 280 plaintiffs, told reporters the proposed payouts are “exceedingly too small” and he expects his clients to opt out and pursue individual lawsuits.
You Can Opt Out: Class members are not required to accept this settlement. Anyone who believes their case warrants a larger recovery can opt out and continue pursuing individual litigation. If you have an existing claim, talk to your attorney before any opt-out deadline passes.
The Payment Structure — It’s Spread Over 21 Years
The $7.25 billion won’t be paid out in a lump sum. Bayer would fund the settlement through annual payments over up to 21 years, subject to caps and declining funding levels over time. Payments are expected to begin in 2026 if the court approves the deal.
That timeline matters. Claimants who are elderly or seriously ill may receive their compensation relatively soon after approval — but the fund’s long-term structure means future claimants diagnosed years from now will be drawing from the same pool, potentially with reduced funding available in later years.
What “Pending Court Approval” Really Means: This is a proposed settlement. The St. Louis Circuit Court must formally approve it before anyone can receive payment. Courts scrutinize class settlements to ensure they’re fair to all members — including people who might not even know they have claims yet. There’s no guarantee of approval, and if enough plaintiffs opt out, Bayer has reserved the right to cancel the deal entirely.
A Supreme Court Wildcard
Layered on top of this settlement is a pending U.S. Supreme Court case, Durnell v. Monsanto, scheduled for oral arguments in April. The case will determine whether EPA’s approval of Roundup legally preempts state-law failure-to-warn claims — meaning whether plaintiffs can even sue in state courts over Roundup’s labeling.
The proposed settlement was structured to protect both sides regardless of how the Supreme Court rules. But the Court’s decision could dramatically affect anyone who opts out to pursue individual claims. If the Court sides with Bayer, opting out could mean being left with far fewer legal options.
Who Is Eligible
- You (or a family member) were exposed to Roundup before mid-February 2026
- You were diagnosed with non-Hodgkin’s lymphoma
- Exposure was either occupational (farm worker, landscaper, golf course maintenance) or residential (backyard, garden use)
- Future claimants diagnosed within 16 years of final court approval may also qualify
- Other types of cancer not currently covered by this settlement
- Claims where there’s no documented Roundup exposure
- Claims already resolved under prior Bayer settlement programs
What to Do If You Think You Have a Claim
If you or someone you love developed non-Hodgkin’s lymphoma after using Roundup, the next steps depend on where you are in the process:
- If you already have an attorney and pending claim: Talk to your lawyer before any deadlines. They will guide you on whether to accept the settlement or opt out.
- If you haven’t filed yet: Consult a mass tort attorney who handles Roundup cases to assess whether your facts qualify and whether it’s worth pursuing given the settlement’s payout scale.
- Monitor the court approval process: A fairness hearing will be scheduled after the settlement is filed. That’s when objectors can speak and the judge evaluates the terms.
The science on glyphosate and cancer is genuinely contested — but what’s not contested is that 125,000 people believed they were harmed enough to sue. A $7.25 billion settlement says Bayer agreed that fighting every case forever wasn’t the smarter financial move.— Steve Rhode
Key Takeaways
- Bayer proposed a $7.25 billion settlement covering ~125,000 Roundup cancer lawsuits — still pending court approval
- Payouts range from ~$10,000 to ~$165,000 depending on age, exposure, and NHL severity
- Fund paid over 21 years, with payments expected to begin in 2026 if approved
- You can opt out — but a pending Supreme Court case could limit legal options for those who do
- Covers both occupational and residential Roundup exposure
Frequently Asked Questions
Is the Bayer Roundup settlement final?
No. The $7.25 billion Roundup settlement was filed February 17, 2026 in Missouri state court and requires judicial approval before taking effect. A fairness hearing will be scheduled as part of the court process. Bayer also reserved the right to cancel the deal if too many plaintiffs opt out.
What cancer does the Roundup settlement cover?
The settlement covers non-Hodgkin’s lymphoma (NHL) claims. Plaintiffs alleged that glyphosate, the active ingredient in Roundup, caused their NHL. Other types of cancer are not covered under this proposed settlement framework.
How much will Roundup settlement claimants receive?
Payouts vary by age at diagnosis, exposure type, and illness severity. Agricultural workers under 60 with aggressive NHL could average approximately $165,000. Residential users diagnosed between ages 60 and 77 could average around $20,000. Those diagnosed at 78 or older average approximately $10,000. These are averages — individual amounts will vary.
Can I still sue Bayer individually over Roundup?
Class members can opt out of this settlement to pursue individual lawsuits. However, a pending U.S. Supreme Court case (Durnell v. Monsanto) could affect the viability of state-law claims depending on its ruling. Anyone with an existing claim should consult their attorney before opting out.
Who was exposed to Roundup?
Both professional and residential users are covered. Agricultural workers, landscapers, golf course employees, and other outdoor workers had the heaviest occupational exposure. Homeowners who used Roundup in gardens, lawns, or around fences may also have residential exposure claims if they later developed non-Hodgkin’s lymphoma.
Sources: Top Class Actions; STAT News; AboutLawsuits.com; IARC — Glyphosate Classification
Dealing With Debt? Understanding your options is the first step. See how all your debt relief options compare — including ones most sites won’t tell you about. The Find Your Path quiz gives a recommendation based on your actual numbers, and the Scam-O-Meter checks any company’s complaint history before you sign. Federal Reserve research shows bankruptcy filers recover faster than those who don’t file.
Claiming money you are owed is one good day. What you do over the following year is what actually changes your position.
In the latest issue (Sep 10): Your phone company is supposed to know who’s handing it those scam calls. Some of them don’t bother.
I write Your Money Actually most weekdays — what I am watching in debt and money, and the small decisions that compound. It is free, I sell nothing, and I take no money from any company I write about.
